Navigation Links
China Sky One Medical, Inc. Launches New Corporate Website
Date:8/11/2009

HARBIN, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced the launch of its new corporate website under the domain name http://www.cski.com.cn .

The new website features an expanded overview of the Company, including its corporate structure, sales network, R&D efforts, as well as a detailed introduction to its product portfolio. The new website also includes a richer section dedicated to investor relations, in keeping with its increased profile in the investor community as a U.S. publicly traded company on the NASDAQ Global Market.

"We are pleased to officially launch our new corporate website, which serves as a resource for customers, investors, and business partners to efficiently access information on our Company," said Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical. "Through frequent and regular updates, we believe our website will become an effective tool to increase awareness of our business and our products within the investment community."

"We welcome direct communications with our shareholders, and look forward to answering any questions that they may have," said Mr. Stanley Hao, CFO of China Sky One Medical. "Should you have any questions about our business and financial statements, please contact us through our outside investor relations firm, CCG Investor Relations, or via email at stanleyhao@cski.com.cn.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the launch of new website. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Stanley Hao, CFO
     Tel:   +86-451-5399-4069
     Email: stanleyhao@cski.com.cn

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Medicine Announces Conference Call to Discuss Second Quarter 2009 Results
2. AlphaRx Receives China Patent on Its Drug Delivery Platform
3. Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products
4. China Medical Technologies Announces Change of Independent Auditors
5. China Pharma Events Keep Growing For UBM
6. Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum
7. China Nepstar Chain Drugstore to Announce Second Quarter 2009 Financial Results on August 24
8. China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20
9. China Pharma Holdings, Inc. to Report Second Quarter 2009 Financial Results on August 12, 2009
10. China Sky One Medical, Inc. to Conduct Non-Deal Roadshow in Hong Kong and Singapore
11. Misonix Receives First Award for Forensic Equipment in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... NexTec Group ... a group of 100 organizations honored for their accomplishments in the field of midmarket ... growth, industry leadership and recognition, and innovation. Selection is not based on revenue and ...
(Date:1/15/2017)... ... January 15, 2017 , ... "On Tour is a music themed slideshow ... ease," said Christina Austin - CEO of Pixel Film Studios. , On Tour’s ... the style and animation of their slideshows. Place each slide on top of another ...
(Date:1/14/2017)... ... January 14, 2017 , ... Healthy living brand Moody Zook ... charcoal products. With more and more people opting to go organic in their ... they cater to specific needs. , Moody Zook focused particularly on their newly ...
(Date:1/13/2017)... ... January 13, 2017 , ... The 18th European Congress: Perspectives in Lung Cancer ... 2017. This Congress is expertly designed to meet the educational needs of European ... cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor of Oncology at the University ...
(Date:1/13/2017)... ... January 13, 2017 , ... An inventor from Virginia Beach, Va., is ... in order to diversify my outfits, so he decided to design something that enhances ... enhances the appearance of a belt to allow for quick, easy changing of its ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... January 13, 2017 This morning, ... how they have fared at yesterday,s closing bell: Clovis ... Inc. (NASDAQ: GALE ), and ACADIA Pharmaceuticals ... cellular and biomolecular processes to develop technologies and products ... footprint, feed the hungry, use less and cleaner energy, ...
(Date:1/13/2017)... , Jan. 13, 2017  Secretary of Health ... professors, and community members at Misericordia University and discussed ... in Pennsylvania . "The ... seen so far in my professional career," Secretary Murphy ... has been hit hard by heroin and prescription opioid ...
(Date:1/13/2017)... -- Research and Markets has announced the addition of ... to their offering. ... Cystic fibrosis (CF) is a progressive genetic condition and is ... conductance regulator (CFTR) gene from both parents. The defective CFTR genes ... in the buildup of a thick and sticky mucus in the ...
Breaking Medicine Technology: